Foundation Medicine, Inc. Announces Timing For First Quarter 2017 Financial Results And Conference Call Post author:Sam Post published:April 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017 In the Nick of Time: Galapagos Nabs Co-Promotion Filgotinib Deal With Gilead December 14, 2017 Cerulean Urges Stockholders To Vote For Proposals At July 19, 2017 Special Stockholder Meeting June 26, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017
Cerulean Urges Stockholders To Vote For Proposals At July 19, 2017 Special Stockholder Meeting June 26, 2017